Important! We do not offer any products ourselves, but offer the possibility to request a treatment (possibly with medication).
If you wish to obtain certain medication, you can buy these products at your own pharmacy or instruct us to arrange this in your name at a registered EU pharmacy. For prescription only medication we also arrange a consultation for you with a registered EU doctor.
* Instruction costs include VAT.
NEWS: Sanofi-aventis is complying with the EMEA's recommendation to temporarily suspend the marketing authorisation of Acomplia® in obese and overweight patients At the moment there is only 1 weight loss medicine as an alternative, which is Xenical. Xenical is clinically proven and safe medication for weight loss. For additional information and ordering of Xenical please visit this link. More information: Paris, October, 23, 2008 - Sanofi-aventis announced today that the European Medicines Agency (EMEA) has recommended to the European Commission (EC) the temporary suspension of the marketing authorisation of Acomplia® (rimonabant) for the approved indication of overweight and obese patients. As a result of this recommendation the sales of the medicine Acomplia has been stopped until futher notice. What is the advice to patients? - Patients who are currently taking Acomplia should consult their doctor or pharmacist at a convenient time to discuss their treatment. - There is no need for patients to stop treatment with Acomplia immediately, but patients who wish to stop can do so at any time. if you are looking for an alternative product, please visit the category Lifestyle 'reductil - xenical - acomplia' -------------------------------------------------------------------------------------------- Acomplia (Rimonabant) tablets contain the active ingredient rimonabant, which is a type of medicine called a cannabinoid-1 receptor antagonist. It is used to aid weight loss in people who are obese or overweight. Acomplia (Rimonabant) works by blocking receptors called cannabinoid-1 receptors (CB1). These are found in the brain, fat tissue, digestive system, liver and muscles. The CB1 receptors are part of a system in the body called the endocannabinoid system. This system has only recently been discovered and explored. It is involved in regulating energy balance, sugar and fat metabolism and body weight. The CB1 receptors found in a particular area of the brain called the mesolimbic system are involved in controlling our intake of highly palatable, sweet or fatty foods. Overactivation of the CB1 receptors is associated with increased appetite, cravings for food and fat build-up. Acomplia (Rimonabant) blocks CB1 receptors and so reduces cravings for these types of foods and helps decrease appetite and control hunger. Acomplia (Rimonabant) may also increase blood levels of "good fats" called HDL-cholesterol and reduce blood levels of "bad fats" called triglycerides. Obesity is caused by consuming more energy in food than than the body needs for the amount of physical activity it is doing. This means that reducing hunger and food cravings is only part of the solution to weight loss. It is important to continue to follow a reduced calorie diet and exercise program while taking this medicine. Ask your doctor for advice about this. At the moment there is only 1 weight loss medicine as an alternative, which is Xenical. Xenical is clinically proven and safe medication for weight loss. For additional information and ordering of Xenical please visit this link.